0310-6540 : Bydureon Bcise 2 mg/.85ml Subcutaneous Injection, Suspension, Extended Release


NDC: 0310-6540
Labeler: Astrazeneca Pharmaceuticals Lp
Product Type: Human Prescription Drug
Drug Name:  Bydureon Bcise
Dosage Form: Subcutaneous Injection, Suspension, Extended Release
Application #: NDA209210
Rev. Date: 


NDC Package Codes:

  • 0310-6540-04: 4 CARTRIDGE IN 1 CARTON (0310‑6540‑04) > .85 ML IN 1 CARTRIDGE (0310‑6540‑01)
  • 0310-6540-85: 1 CARTRIDGE IN 1 CARTON (0310‑6540‑85) > .85 ML IN 1 CARTRIDGE

Active Ingredients:

  • Exenatide

Dosage Strength:

  • 2 mg/.85mL

Pharmaceutical Classes:

  • GLP-1 Receptor Agonist [EPC]
  • Glucagon-Like Peptide 1 [CS]
  • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0310-6540 QR Code

< Prev: 0310-6530Next: 0310-6615 >

Related Discussions:

exenatide
diabitis...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.